ABOUT US
About Company
Investors
CSR
PIPELINE
CDP
Product
Publication
NEWS
Corporate News
Media Reports
CAREER
Talents Value
Talents Acquisition
CONTACTS
中文
/
en
ABOUT US
About Company
Investors
CSR
PIPELINE
CDP
Product
Publication
NEWS
Corporate News
Media Reports
CAREER
Talents Value
Talents Acquisition
CONTACTS
Phone: +86 21 63862192
Mailbox: info@alphabiopharma.com
Shanghai: Unit 02-05, 11/F, East Tower, Raffles City The Bund No.1089 Dong Daming Road, Shanghai 200082, China
Beijing: Room 2512, The Place Tower, No. 9 Guanghua Road, Chaoyang District, Beijing
Share :
NEWS
Corporate News
Corporate News
Media Reports
NEWS
07/20
2022
Wugen Receives U.S. FDA F...
Wugen today announced that the U.S. Food and Drug Administration (FDA) ...
view more
06/11
2022
Wugen Presents New Preclinic...
Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of o...
view more
03/16
2022
Wugen Announces First Patien...
WU-CART-007 granted FDA Orphan Drug Designation for the treatment of...
view more
09/18
2021
Immunotherapy product developme...
On September 18, 2021, Alpha Biopharma announced that its immunotherapy prod...
view more
05/04
2020
Video seminar for EVEREST...
Video seminar for EVEREST study successfully held in Shanghai
view more
02/05
2020
Patient first:Alpha Biopharm...
Patient first:Alpha Biopharma fulfills its mission and serves patients whole...
view more
10/01
2019
“Precise Innovation, Smart F...
“Precise Innovation, Smart Future”- Insight from Alpha Biopharma on 201...
view more
05/28
2019
“Focus on The Future”- Alp...
In order to continuously improve the quality of work in clinical trials, nearly...
view more
1
2